NEWPORT BEACH, CA–(Marketwired – Jun 7, 2016) – Advantis Corp. (OTC PINK: ADVT) and Hemp2Health, LLC, a Colorado company, have engaged in a critical letter of intent to provide high grade CBD oil extract to Advantis for its product lines. This strategic alliance will fortify Advantis with a most crucial component for developing and deploying nutraceuticals containing high grade CBD required by our Chief Medic, Dr. Elgin. “Hemp2Health has a solid team with 60 or more years of collective experience in the HEMP Production Space, and we are confident that they will be able to consistently provide a product with the quality standards that Advantis requires for its product line.” More information on Hemp2Health is available at www.hemp2health.com.
HEMP2HEALTH CBD’S IN A CLASS OF ITS OWN
Over 400 phytonutrients exist in our CBD Rich Hemp Genetics. H2H employs an Extraction technology that allows for the extraction of these nutrients without the use of heat or harmful solvents. The result is a full-spectrum nutraceutical food product with exceptional nutritional qualities; providing the benefits of the whole plant in an easy to use and easy to digest form.
About ADVANTIS CORP
Advantis Corp. develops products and works with developing companies to provide innovative healthcare products, holistic pain management solutions, and enhance our footprint in the evolving HEMP Markets. Advantis acquires ownership in developing companies that work within the nutraceutical and the alternative healthcare industries; consulting with these organizations to improve their product lines, expand their distribution channels through our internal partnership agreements, and heighten brand value.
Safe Harbor Statement
Forward Looking Statements: This press release may contain certain”forward-looking statements” relating to the business of ADVANTIS CORP. and its subsidiary companies. All statements, other than statements of historical fact included herein are “forward-looking statements.” These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects” or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website at http://www.sec.gov. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.